Loading...

1,830 posters, 67 videos, 75 audios, 29 topics, 22 sessions, 4,727 authors, 1,697 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2023

June 12 - 14, 2023 | London, UK

RCOG World Congress 2023 banner

EP.1548

Case of cervical tuberculosis presenting as growth

Part of Topic

Benign Gynaecology

 case
  • A nulliparous, newly married female of 24.5 yrs presented with complaint of offensive, blood mixed vaginal discharge for a few months, post coital bleeding and intermittent spotting.
  • Patient also had complaint of mild dull aching pelvic pain and dyspareunia. Bowel and bladder habits normal.
  • Examination suggested a lean built with mild pallor. 
  • On per speculum examination, cervix revealed friable cervix, bleeds on touch with small papillary growth like lesions.
  • No dysmenorrhoea, no heavy bleeding. No significant medical, surgical or family history.
  • Patient had history of weight loss and loss of appetite for a few months.
  • Image 1. showing friable cervix. Small ulcerative lesion at 9 o’clock. 
  • Cervix bleeds on touch.
  • As shown in image 2, copious white discharge present.
  • Decision of pap smear and biopsy taken. Lesion turned out to be tubercular in origin.
  • Further labortatory tests including complete blood count, TB Platinum, liver function tests were done.
  • Ultrasound done to tule out any pelvic collections.
  • Final diagnosis of Tuberculosis of cervix made.
  • Treatment plan of Antitubercular treatment made for a duration of 6 - 9 months as per the recommendations.
  • At present patient has completed 4 months of treatment. There is significant improvement in cervical discharge and inflammation and overall general health but patient still complaints of occasional post coital bleeding.
  • Barrier contraception has been advised for the duration and patient had husband both had been investigated for HIV status. It has come out negative on two separate occasions 3 months apart.
  • Husband has also been investigated for Tuberculosis. He has tested negative. 
  • Discussion
  • though a rare presentation in developed world, is fairly common in developing countries.(1) Incidence of cervical tuberculosis when compared to overall cases is 0.1 - 0.65% where as in cases of genital tuberculosis it varies from 5 - 24% most common affected part being fallopian tubes. (2)
  • Generally primary focus is elsewhere spread to cervix via hematogenous and lymphatic spread. In rare cases primary lesion might be cervix. it is  more commonly sees in immunocompromised cases. (3,4,5)
  • Most cases have been reported in reproductive age groups but a few cases have been reported in post menopausal age group as well. (6) 

 

  • Macroscopic findings include papillary and vegetative growth, ulcerative lesions mimicking carcinomatous changes. (7)
  • Microscopically there casesting/granulomatous changes. (7)
  • Gold standard is Mycobacterium tuberculosis on biopsy. Though they may not be seen in one third of the cases. (7) 
  • Treatment plan included Anti tubercular regimen involving Isoniazid, Rifampin, Ethambutol and pyrazinamide for six to nine months.

BIbliography

Bibliography
1 .TripathySNe tal(1998)Gynaecologicaltuberculosis:anupdate.I n dJ Tub45:193.
2
.JournalofMid-lifeHealth! Apr-Jun2014| Vol5 | IssueCarterJR.Unusualpresentationso fgenitaltract tuberculosis.IntJ GynaecolObstet1990;33:171-6.
3
.KollerAB.Granulomatouslesionsoft h ecervixuteriinblackpatients.SouthAfrMedJ1975;49:1228-32
4
.RichardsMJ,AngusD.Possiblesexualtransmissiono fgenitourinarytuberculosis.I n tJ TBLungDis 1998;2:439.
5
.ChowdhuryN R .Overviewoftuberculosisoft h efemalegenitaltract.J IndianM e dAssoc1996;94:345-61.
6
.Tuberculosisofthecervix:Anuncommoncauseofvaginaldischargeinapost-menopausalwoman.Rajesh KumariandAlkaKriplanie ta l .TheNationalMedicalJournalOfIndia.ClinicalCaseReport2018:31:3;149-150
7
doi:10.4103/0970-258X.255757PMID:31044761.
.

RCOG World Congress 2023 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.